HK1151991A1 - Tablet having improved elution properties - Google Patents

Tablet having improved elution properties

Info

Publication number
HK1151991A1
HK1151991A1 HK11106250.9A HK11106250A HK1151991A1 HK 1151991 A1 HK1151991 A1 HK 1151991A1 HK 11106250 A HK11106250 A HK 11106250A HK 1151991 A1 HK1151991 A1 HK 1151991A1
Authority
HK
Hong Kong
Prior art keywords
tablet
elution properties
improved elution
improved
properties
Prior art date
Application number
HK11106250.9A
Other languages
English (en)
Chinese (zh)
Inventor
柳田萬希子
西井宏行
中園昌幸
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Publication of HK1151991A1 publication Critical patent/HK1151991A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11106250.9A 2008-02-11 2011-06-17 Tablet having improved elution properties HK1151991A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6401208P 2008-02-11 2008-02-11
PCT/JP2009/052231 WO2009101940A1 (ja) 2008-02-11 2009-02-10 溶出性の改善された錠剤

Publications (1)

Publication Number Publication Date
HK1151991A1 true HK1151991A1 (en) 2012-02-17

Family

ID=40956971

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11106250.9A HK1151991A1 (en) 2008-02-11 2011-06-17 Tablet having improved elution properties

Country Status (8)

Country Link
US (2) US8673353B2 (xx)
EP (1) EP2251012A4 (xx)
JP (1) JP5401327B2 (xx)
KR (1) KR20100121483A (xx)
CN (1) CN101945657B (xx)
CA (1) CA2714524A1 (xx)
HK (1) HK1151991A1 (xx)
WO (1) WO2009101940A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2784996A1 (en) * 2009-12-22 2011-06-30 Novartis Ag Formulation comprising 1 h-quinazoline-2,4-dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof
GB201003766D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
JP5167389B2 (ja) * 2010-07-07 2013-03-21 日本たばこ産業株式会社 クエン酸第二鉄を含む錠剤
DK2851075T3 (da) 2012-05-14 2022-01-31 Shionogi & Co Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat
EP2674149B1 (en) * 2012-06-15 2017-10-04 Shin-Etsu Chemical Co., Ltd. Method of preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation
JP6590822B2 (ja) * 2014-10-10 2019-10-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 縮合アミノジヒドロチアジン誘導体の医薬組成物
WO2016072179A1 (ja) * 2014-11-05 2016-05-12 日本酢ビ・ポバール株式会社 フィルムコーティング組成物並びに経口固形製剤及びその製造方法
WO2016181276A1 (en) * 2015-05-08 2016-11-17 Wockhardt Limited Stable pharmaceutical compositions comprising antibacterial agent
JP2019142814A (ja) * 2018-02-21 2019-08-29 大原薬品工業株式会社 フェブキソスタット含有錠剤の製造方法
JP6887456B2 (ja) 2018-07-04 2021-06-16 キャプシュゲル・ベルジウム・エヌ・ヴィ 白色化剤として界面活性剤又は界面活性剤と塩を含有する皮膜形成性組成物
KR102222774B1 (ko) * 2018-07-27 2021-03-04 보령제약 주식회사 에독사반을 포함하는 약학적 제제 및 이의 제조방법
EP3875091A4 (en) * 2018-10-31 2021-12-29 FUJIFILM Corporation Pharmaceutical composition containing antitumor agent
EP3875089A4 (en) * 2018-10-31 2021-12-22 FUJIFILM Corporation TABLET CONTAINING AN ANTI-TUMOR AGENT
JP7145121B2 (ja) * 2019-05-31 2022-09-30 信越化学工業株式会社 錠剤の製造方法
EP3983477B1 (en) * 2019-06-12 2022-11-02 Capsugel Belgium NV Film, capsule and film-forming composition comprising water-soluble salt as opacifying agent
JP7339057B2 (ja) * 2019-08-06 2023-09-05 ライオン株式会社 ラクトフェリン含有腸溶錠及びその製造方法
JPWO2023149546A1 (xx) * 2022-02-04 2023-08-10

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
JP4022269B2 (ja) 1995-05-26 2007-12-12 協和醗酵工業株式会社 医薬組成物
JPH11199517A (ja) * 1997-10-31 1999-07-27 Meiji Seika Kaisha Ltd 口腔内速崩壊性錠剤
JP4063386B2 (ja) 1998-01-29 2008-03-19 キッセイ薬品工業株式会社 速放性経口医薬品組成物
CA2345516A1 (en) 1998-11-19 2000-05-25 Dupont Pharmaceuticals Company Crystalline (-)-6- chloro-4- cyclopropylethynyl- 4-trifluoromethyl- 3,4-dihydro- 2(1h)-quinazolinone
JP2001347153A (ja) * 2000-06-12 2001-12-18 Asahi Kasei Corp 錠剤の製造方法
DK1327440T5 (da) 2000-09-22 2009-09-07 Dainippon Sumitomo Pharma Co Orale pr parater med gunstige nedbrydningsegenskaber
JP2004331500A (ja) * 2001-02-16 2004-11-25 Dainippon Pharmaceut Co Ltd 血中濃度制御製剤
DE60223151T2 (de) * 2001-08-09 2008-08-07 Dainippon Sumitomo Pharma Co., Ltd. Chinazolinonderivat
JP4684545B2 (ja) * 2002-09-26 2011-05-18 大日本住友製薬株式会社 溶出性の良好なイソキサゾール誘導体経口製剤
JPWO2004078173A1 (ja) 2003-02-05 2006-06-08 塩野義製薬株式会社 溶出性の改善された錠剤
US20050142192A1 (en) * 2003-10-15 2005-06-30 Wyeth Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives
JP5036126B2 (ja) * 2004-10-19 2012-09-26 日医工株式会社 エバスチン経口投与用製剤
JP2006188466A (ja) * 2005-01-07 2006-07-20 Dainippon Sumitomo Pharma Co Ltd 過活動膀胱治療薬としてのキナゾリノン誘導体
MX2007014872A (es) * 2005-05-26 2008-02-15 Dainippon Sumitomo Pharma Co Composicion farmaceutica.
PE20070077A1 (es) * 2005-06-10 2007-02-07 Takeda Pharmaceutical Comprimido con recubierta con azucar
WO2007148786A1 (ja) * 2006-06-23 2007-12-27 Takeda Pharmaceutical Company Limited 安定化された固形製剤

Also Published As

Publication number Publication date
CN101945657B (zh) 2015-04-22
EP2251012A4 (en) 2013-03-06
US8673353B2 (en) 2014-03-18
US20140135352A1 (en) 2014-05-15
EP2251012A1 (en) 2010-11-17
CA2714524A1 (en) 2009-08-20
JPWO2009101940A1 (ja) 2011-06-09
US20110027362A1 (en) 2011-02-03
KR20100121483A (ko) 2010-11-17
US9463164B2 (en) 2016-10-11
WO2009101940A1 (ja) 2009-08-20
CN101945657A (zh) 2011-01-12
JP5401327B2 (ja) 2014-01-29

Similar Documents

Publication Publication Date Title
HK1151991A1 (en) Tablet having improved elution properties
EP2345399A4 (en) TABLE FEEDING SYSTEM
ZA201003971B (en) Granules
EP2212908A4 (en) JUNCTION FIELD EFFECT TRANSISTOR WITH AILET
DE602008005470D1 (en) Imidazopyridinone
EP2160187A4 (en) SPIROINDALONE
EP2145244A4 (en) MOUSE
AP2010005314A0 (en) Nanodispersian
EP2211752A4 (en) BIOPULPA
EP2249646A4 (en) PDE4 muscarinic Antagonist-DOPPELPHARMACOPHOREN
IL205200A0 (en) Improved tablet coating
IL207352A0 (en) Dual pharmacophores - pde4 - muscarinic antagonistics
IL207351A0 (en) Dual pharmacophores - pde4 - muscarinic antagonistics
IL207346A0 (en) Dual pharmacophores - pde4 - muscarinic antagonistics
GB2454529B (en) Supports
EP2249830A4 (en) DUAL PHARMACOPHORES, ANTAGONISTS OF MUSCARINIC RECEPTORS AND INHIBITORS OF PDE4 ACTIVITY
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
AU3646P (en) TAS300 Dianella tasmanica
AU3595P (en) Goldust Strobilanthes anisophyllus
AU3952P (en) FLOCHRDEF Chrysocephalum apiculatum
AU3702P (en) DarwinGold Dianella ensifolia
AU3642P (en) TAS100 Dianella tasmanica
AU3613P (en) LS005A01 Leucospermum cuneiforme
AU3606P (en) Jaywick xTriticosecale
AU2007236V (en) Newpladia1 Dianella caerulea

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200209